• 1
    Petrulio CA,Kim-Schulze S,Kaufman HL. The tumour microenvironment and implications for cancer immunotherapy. Exp Opin Biol Ther 2006; 6: 67184.
  • 2
    Barreda DR,Hanington PC,Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol 2004; 28: 50954.
  • 3
    Williams ME,Quesenberry PJ. Hematopoietic growth factors. Hematol Pathol 1992; 6: 10524.
  • 4
    Griffin JD,Cannistra SA,Sullivan R,Demetri GD,Ernst TJ,Kanakura Y. The biology of GM-CSF: regulation of production and interaction with its receptor. Int J Cell Cloning 1990; 8( Suppl 1): 3544; discussion 44–45.
  • 5
    Martinez-Moczygemba M,Huston DP. Biology of common β receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clin Immunol 2003; 112: 65365; quiz 66.
  • 6
    Wu FP,Westphal JR,Hoekman K,Mels AK,Statius Muller MG,de Waal RW,Beelen RH,van Leeuwen PA,Meijer S,Cuesta MA. The effects of surgery, with or without rhGM-CSF, on the angiogenic profile of patients treated for colorectal carcinoma. Cytokine 2004; 25: 6872.
  • 7
    Ninck S,Reisser C,Dyckhoff G,Helmke B,Bauer H,Herold-Mende C. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck. Int J Cancer 2003; 106: 3444.
  • 8
    Dale DC. Colony-stimulating factors for the management of neutropenia in cancer patients. Drugs 2002; 62( Suppl 1): 115.
  • 9
    Palmeri S,Leonardi V,Danova M,Porta C,Ferrari S,Fincato G,Citarrella P. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients. Haematologica 1999; 84: 101623.
  • 10
    Mueller MM,Herold-Mende CC,Riede D,Lange M,Steiner HH,Fusenig NE. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am J Pathol 1999; 155: 155767.
  • 11
    Mueller MM,Peter W,Mappes M,Huelsen A,Steinbauer H,Boukamp P,Vaccariello M,Garlick J,Fusenig NE. Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Am J Pathol 2001; 159: 156779.
  • 12
    Obermueller E,Vosseler S,Fusenig NE,Mueller MM. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res 2004; 64: 780112.
  • 13
    Braun B,Lange M,Oeckler R,Mueller MM. Expression of G-CSF and GM-CSF in human meningiomas correlates with increased tumor proliferation and vascularization. J Neurooncol 2004; 68: 13140.
  • 14
    Ciotti P,Imro A,Scudeletti M,Rainero ML,Defferrari R,Ghiorzo P,Indiveri F,Bianchi-Scarra G. MEL-P, a GM-CSF-producing human melanoma cell line. Melanoma Res 1996; 6: 20313.
  • 15
    Kohn EC,Hollister GH,DiPersio JD,Wahl S,Liotta LA,Schiffmann E. Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration. Int J Cancer 1993; 53: 96872.
  • 16
    Young MR,Halpin J,Hussain R,Lozano Y,Djordjevic A,Devata S,Matthews JP,Wright MA. Inhibition of tumor production of granulocyte-macrophage colony-stimulating factor by 1 α, 25-dihydroxyvitamin D3 reduces tumor motility and metastasis. Invasion Metastasis 1993; 13: 16977.
  • 17
    Dhar-Mascareno M,Pedraza A,Golde DW. PI3-kinase activation by GM-CSF in endothelium is upstream of Jak/Stat pathway: role of αGMR. Biochem Biophys Res Commun 2005; 337: 5516.
  • 18
    Gutschalk CM,Herold-Mende CC,Fusenig NE,Mueller MM. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res 2006; 66: 802636.
  • 19
    Jubb AM,Oates AJ,Holden S,Koeppen H. Predicting benefit from anti-angiogenic agents in malignancy. Nat Rev 2006; 6: 62635.
  • 20
    Bikfalvi A,Han ZC. Angiogenic factors are hematopoietic growth factors and vice versa. Leukemia 1994; 8: 5239.
  • 21
    Bishop ET,Bell GT,Bloor S,Broom IJ,Hendry NF,Wheatley DN. An in vitro model of angiogenesis: basic features. Angiogenesis 1999; 3: 33544.
  • 22
    Korff T,Augustin HG. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol 1998; 143: 134152.
  • 23
    Kunz-Schughart LA,Schroeder JA,Wondrak M,van Rey F,Lehle K,Hofstaedter F,Wheatley DN. Potential of fibroblasts to regulate the formation of three-dimensional vessel-like structures from endothelial cells in vitro. Am J Physiol Cell Physiol 2006; 290: C1385C1398.
  • 24
    Murphy G,Willenbrock F. Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol 1995; 248: 496510.
  • 25
    Baker AH,Zaltsman AB,George SJ,Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 1998; 101: 147887.
  • 26
    Sounni NE,Roghi C,Chabottaux V,Janssen M,Munaut C,Maquoi E,Galvez BG,Gilles C,Frankenne F,Murphy G,Foidart JM,Noel A. Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases. J Biol Chem 2004; 279: 1356474.
  • 27
    Sithu SD,English WR,Olson P,Krubasik D,Baker AH,Murphy G,D'souza SE. Membrane type 1-matrix metalloproteinase (MT1-MMP) regulates intracellular adhesion molecule-1 (ICAM-1) mediated monocyte transmigration. J Biol Chem 2007; 282: 250109.
  • 28
    Nickin S,Baker A. Simple methods for preparing recombinant adenoviruses for high-efficiency transduction of vascular cells. In: BakerAH, ed. Vascular disease: Molecular biology and gene transfer protocols, vol. 30. New York: Humana, 1999. 27184.
  • 29
    d'Ortho MP,Stanton H,Butler M,Atkinson SJ,Murphy G,Hembry RM. MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS Lett 1998; 421: 15964.
  • 30
    Nuttall RK,Pennington CJ,Taplin J,Wheal A,Yong VW,Forsyth PA,Edwards DR. Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. Mol Cancer Res 2003; 1: 33345.
  • 31
    Davis GE,Saunders WB. Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. J Invest Dermatol Symp Proc 2006; 11: 4456.
  • 32
    Nagase H,Visse R,Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006; 69: 56273.
  • 33
    Itoh Y,Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 2006; 206: 18.
  • 34
    Remacle A,Murphy G,Roghi C. Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface. J Cell Sci 2003; 116: 390516.
  • 35
    Boyd PJ,Doyle J,Gee E,Pallan S,Haas TL. MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2. Am J Physiol Cell Physiol 2005; 288: C659C668.
  • 36
    Stanton H,Gavrilovic J,Atkinson SJ,d'Ortho MP,Yamada KM,Zardi L,Murphy G. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J Cell Sci 1998; 111(Part 18): 278998.
  • 37
    Toth M,Hernandez-Barrantes S,Osenkowski P,Bernardo MM,Gervasi DC,Shimura Y,Meroueh O,Kotra LP,Galvez BG,Arroyo AG,Mobashery S,Fridman R. Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme. J Biol Chem 2002; 277: 2634050.
  • 38
    Huovila AP,Turner AJ,Pelto-Huikko M,Karkkainen I,Ortiz RM. Shedding light on ADAM metalloproteinases. Trends Biochem Sci 2005; 30: 41322.
  • 39
    Overall CM,Kleifeld O. Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Br J Cancer 2006; 94: 9416.
  • 40
    Lafleur MA,Handsley MM,Knauper V,Murphy G,Edwards DR. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J Cell Sci 2002; 115: 342738.
  • 41
    Collen A,Hanemaaijer R,Lupu F,Quax PH,van Lent N,Grimbergen J,Peters E,Koolwijk P,van Hinsbergh VW. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Blood 2003; 101: 181017.
  • 42
    Chun TH,Sabeh F,Ota I,Murphy H,McDonagh KT,Holmbeck K,Birkedal-Hansen H,Allen ED,Weiss SJ. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol 2004; 167: 75767.
  • 43
    Lehti K,Allen E,Birkedal-Hansen H,Holmbeck K,Miyake Y,Chun TH,Weiss SJ. An MT1-MMP-PDGF receptor-β axis regulates mural cell investment of the microvasculature. Genes Dev 2005; 19: 97991.
  • 44
    Genis L,Galvez BG,Gonzalo P,Arroyo AG. MT1-MMP: universal or particular player in angiogenesis? Cancer Metastasis Rev 2006; 25: 7786.
  • 45
    Varon C,Tatin F,Moreau V,Van Obberghen-Schilling E,Fernandez-Sauze S,Reuzeau E,Kramer I,Genot E. Transforming growth factor β induces rosettes of podosomes in primary aortic endothelial cells. Molecular Cell Biol 2006; 26: 358294.
  • 46
    Plaisier M,Kapiteijn K,Koolwijk P,Fijten C,Hanemaaijer R,Grimbergen JM,Mulder-Stapel A,Quax PH,Helmerhorst FM,van Hinsbergh VW. Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3-MMP. J Clin Endocrinol Metab 2004; 89: 582836.
  • 47
    Galvez BG,Genis L,Matias-Roman S,Oblander SA,Tryggvason K,Apte SS,Arroyo AG. Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/ccl2 and interleukin-8/CXCL8 in endothelial cells during angiogenesis. J Biol Chem 2005; 280: 12928.
  • 48
    Takino T,Miyamori H,Watanabe Y,Yoshioka K,Seiki M,Sato H. Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration. Cancer Res 2004; 64: 10449.
  • 49
    Ispanovic E,Haas TL. JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to actin cytoskeleton reorganization in endothelial cells. Am J Physiol Cell Physiol 2006; 291: C579C588.
  • 50
    Eubank TD,Roberts R,Galloway M,Wang Y,Cohn DE,Marsh CB. GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice. Immunity 2004; 21: 83142.
  • 51
    Tomita T,Fujii M,Tokumaru Y,Imanishi Y,Kanke M,Yamashita T,Ishiguro R,Kanzaki J,Kameyama K,Otani Y. Granulocyte-macrophage colony-stimulating factor upregulates matrix metalloproteinase-2 (MMP-2) and membrane type-1 MMP (MT1-MMP) in human head and neck cancer cells. Cancer Lett 2000; 156: 8391.